Thermo Fisher price target lowered to $605 from $650 at Scotiabank

Scotiabank lowered the firm’s price target on Thermo Fisher (TMO) to $605 from $650 and keeps a Sector Perform rating on the shares. While it is not yet clear whether the potential pharma tariffs could become material headwinds for the company, but the firm believes Thermo Fisher remains well positioned to mitigate additional risks while capitalizing on long-term growth opportunities, the analyst tells investors.